Understanding the Global Ankylosing Spondylitis Market: Trends, Treatment, and Projections to 2032
Ankylosing Spondylitis Market: Trends, Treatment, and Projections
PORTLAND, OREGON, UNITED STATES, July 17, 2024 /EINPresswire.com/ -- 𝑬𝒏𝒒𝒖𝒊𝒓𝒆 𝑩𝒆𝒇𝒐𝒓𝒆 𝑩𝒖𝒚𝒊𝒏𝒈: https://www.alliedmarketresearch.com/purchase-enquiry/A10281
Market Overview
• Market Size and Growth: The global ankylosing spondylitis market was valued at $5,140.94 million in 2020 and is expected to reach $8,110.59 million by 2030, with a CAGR of 4.6% from 2021 to 2030.
• Disease Overview: Ankylosing spondylitis is an inflammatory disease causing spinal vertebrae fusion, leading to reduced flexibility and potentially severe complications like breathing difficulties.
Symptoms and Diagnosis
• Early Signs: Includes morning stiffness, lower back and hip pain, neck pain, and fatigue.
• Diagnosis: Primarily through physical examination, supported by MRI and X-ray imaging.
Treatment and Management
• Current Approaches: Focus on symptom management as there is no known cure.
• Medications: NSAIDs, TNF inhibitors, corticosteroids, and DMARDs are commonly used.
• Emerging Therapies: Monoclonal antibodies like Taltz have shown efficacy in reducing inflammation and pain.
Market Drivers
• Prevalence: Increasing global prevalence, with significant screening results such as 7.3% positivity in Spain.
• Healthcare Infrastructure: Growth in orthopedic hospitals and diagnostic centers enhancing disease detection and treatment.
• Therapeutic Advancements: FDA approvals and advancements in therapy contribute to market expansion.
Market Segmentation
• By Drug Class: Dominated by NSAIDs; TNF inhibitors showing promising growth.
• By Distribution Channel: Major channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Insights
• North America: Largest market share due to high disease prevalence, robust healthcare infrastructure, and key player presence.
• Asia-Pacific: Expected highest growth rate (CAGR 6.1%) due to increasing healthcare facilities and population base.
Key Players
• Leading Companies: AbbVie, Amgen, Pfizer, Novartis, Lilly, among others, driving innovation and market growth.
Challenges
• Cost and Side Effects: High therapy costs and potential adverse drug effects pose challenges to market growth.
𝑬𝒏𝒒𝒖𝒊𝒓𝒆 𝑩𝒆𝒇𝒐𝒓𝒆 𝑩𝒖𝒚𝒊𝒏𝒈: https://www.alliedmarketresearch.com/purchase-enquiry/A10281
David Correa
Allied Market Research
email us here
+1 800-792-5285
Visit us on social media:
Facebook
X
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
